Literature DB >> 1848427

Peri-operative mortality in hepatic resection.

J J Tjandra1, S T Fan, J Wong.   

Abstract

The operative results of hepatic resections (n = 67) during the past 28 months are reported. Major hepatic resection (lobectomy, extended lobectomy) was performed in 78% of patients with hepatocellular carcinoma (HCC) and in 24% of patients with non-HCC diseases. The overall operative mortality was 10%: 15% for HCC and 0% for non-HCC diseases. The operative mortality in the HCC group occurred exclusively in patients who had undergone right or extended right lobectomy. The operative mortality of right or extended right lobectomy in patients with HCC increased considerably with the presence of cirrhosis (32% vs 0%) and a liver function worse than Child's A (60% vs 17%). In HCC, the incidence of operative mortality (47%) and postoperative hepatic failure (73%) was higher when there had been massive operative blood loss (greater than or equal to 4.0 L) and/or persistent postoperative haemorrhage, compared with 0% and 24% respectively in cases without massive peri-operative bleeding. While postoperative hepatic failure was present in 5 of 7 fatalities, it was not an independent prognostic factor, but was dependent on the presence of massive peri-operative blood loss.

Entities:  

Mesh:

Year:  1991        PMID: 1848427     DOI: 10.1111/j.1445-2197.1991.tb07592.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  10 in total

1.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 2.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

Review 3.  Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma.

Authors:  Mark J Truty; Jean-Nicolas Vauthey
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

4.  Anterior approach for major right hepatic resection for large hepatocellular carcinoma.

Authors:  C L Liu; S T Fan; C M Lo; R Tung-Ping Poon; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

5.  Total vascular exclusion technique for resection of hepatocellular carcinoma.

Authors:  Zhen-Yu Yin; Xiao-Ming Wang; Ren-Xiang Yu; Bai-Meng Zhang; Ke-Ke Yu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 6.  [Liver resections for primary liver malignancies. Personal results and analysis of the literature].

Authors:  J Zieren; H U Zieren; J M Müller
Journal:  Langenbecks Arch Chir       Date:  1994

7.  Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy.

Authors:  Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu; Tian-Yi Chi; Xue Wei; Kai Han; Ning Zhang; Hai-Tao Zhao
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

8.  Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions.

Authors:  David Li; David C Madoff
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

9.  Hepatocellular carcinoma: natural history, current management, and emerging tools.

Authors:  Christopher L Tinkle; Daphne Haas-Kogan
Journal:  Biologics       Date:  2012-07-17

10.  Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased?

Authors:  Lucas McCormack; Pablo Capitanich; Emilio Quiñonez
Journal:  Patient Saf Surg       Date:  2008-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.